In spite of this, it is important to note that recombinant human IFNα2b is indicated for the treatment of various human chronic viral infections associated with malignant conditions such as acquired immune deficiency syndrome (AIDS)-related Kaposi’s sarcoma, human papilloma virus (HPV)-caused condyloma acuminata, and chronic hepatitis C (HCV) or hepatitis B (HBV) infections [201,202,203,204]. The gene discussed is IFNA2; the disease is infection.